Henry Schein (NASDAQ:HSIC) Earns Equal Weight Rating from Analysts at Wells Fargo & Company

Wells Fargo & Company initiated coverage on shares of Henry Schein (NASDAQ:HSIC) in a report published on Friday, MarketBeat Ratings reports. The firm issued an equal weight rating and a $80.00 price target on the stock.

Several other equities analysts have also weighed in on the stock. Bank of America upgraded shares of Henry Schein from an “underperform” rating to a “buy” rating and increased their price target for the company from $69.00 to $84.00 in a research report on Monday, January 6th. Mizuho initiated coverage on shares of Henry Schein in a research report on Wednesday, December 4th. They set a “neutral” rating and a $75.00 target price for the company. Barrington Research increased their target price on shares of Henry Schein from $82.00 to $90.00 and gave the stock an “outperform” rating in a research report on Thursday, January 30th. StockNews.com upgraded shares of Henry Schein from a “sell” rating to a “hold” rating in a research report on Thursday, November 7th. Finally, Jefferies Financial Group increased their target price on shares of Henry Schein from $77.00 to $80.00 and gave the stock a “hold” rating in a research report on Thursday, January 23rd. Eight investment analysts have rated the stock with a hold rating, five have assigned a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat, Henry Schein presently has an average rating of “Moderate Buy” and an average price target of $80.09.

Henry Schein Price Performance

HSIC opened at $76.00 on Friday. The firm has a market cap of $9.48 billion, a P/E ratio of 31.28, a PEG ratio of 2.21 and a beta of 0.91. The firm has a 50-day moving average of $74.01 and a 200 day moving average of $72.00. The company has a debt-to-equity ratio of 0.46, a quick ratio of 0.82 and a current ratio of 1.42. Henry Schein has a fifty-two week low of $63.67 and a fifty-two week high of $82.63.

Insider Activity at Henry Schein

In other news, COO Michael S. Ettinger sold 12,240 shares of the firm’s stock in a transaction that occurred on Monday, November 18th. The shares were sold at an average price of $75.00, for a total value of $918,000.00. Following the transaction, the chief operating officer now owns 87,706 shares in the company, valued at approximately $6,577,950. This trade represents a 12.25 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. 1.14% of the stock is currently owned by insiders.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently made changes to their positions in the company. Cromwell Holdings LLC grew its holdings in shares of Henry Schein by 93.4% in the third quarter. Cromwell Holdings LLC now owns 352 shares of the company’s stock worth $26,000 after purchasing an additional 170 shares during the last quarter. Versant Capital Management Inc grew its holdings in shares of Henry Schein by 274.6% in the fourth quarter. Versant Capital Management Inc now owns 457 shares of the company’s stock worth $32,000 after purchasing an additional 335 shares during the last quarter. Venturi Wealth Management LLC grew its holdings in shares of Henry Schein by 3,347.1% in the fourth quarter. Venturi Wealth Management LLC now owns 586 shares of the company’s stock worth $41,000 after purchasing an additional 569 shares during the last quarter. Quent Capital LLC grew its holdings in shares of Henry Schein by 91.2% in the fourth quarter. Quent Capital LLC now owns 677 shares of the company’s stock worth $47,000 after purchasing an additional 323 shares during the last quarter. Finally, Smartleaf Asset Management LLC grew its holdings in shares of Henry Schein by 23.2% in the fourth quarter. Smartleaf Asset Management LLC now owns 759 shares of the company’s stock worth $52,000 after purchasing an additional 143 shares during the last quarter. Institutional investors own 96.62% of the company’s stock.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.